189 related articles for article (PubMed ID: 30655593)
1. Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection.
Juvale K; Purushothaman G; Singh V; Shaik A; Ravi S; Thiruvenkatam V; Kirubakaran S
Sci Rep; 2019 Jan; 9(1):190. PubMed ID: 30655593
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and In Vitro Enzymatic Studies of New 3-Aryldiazenyl Indoles as Promising Helicobacter pylori IMPDH Inhibitors.
Jangra S; Purushothaman G; Juvale K; Ravi S; Menon A; Thiruvenkatam V; Kirubakaran S
Curr Top Med Chem; 2019; 19(5):376-382. PubMed ID: 30827248
[TBL] [Abstract][Full Text] [Related]
3. Studies on Methylpyrazole-Substituted Benzimidazoles to Target
Dilip H; Thiruvenkatam V; Kirubakaran S
ACS Infect Dis; 2024 Jun; 10(6):2262-2275. PubMed ID: 38787329
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2.
Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS
Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
[TBL] [Abstract][Full Text] [Related]
6. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors.
Galal AMF; Mohamed HS; Abdel-Aziz MM; Hanna AG
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000385. PubMed ID: 33576040
[TBL] [Abstract][Full Text] [Related]
7. Irigenin, a novel lead from Iris confusa for management of Helicobacter pylori infection with selective COX-2 and HpIMPDH inhibitory potential.
Abdel-Baki PM; El-Sherei MM; Khaleel AE; Abdel-Aziz MM; Okba MM
Sci Rep; 2022 Jul; 12(1):11457. PubMed ID: 35794127
[TBL] [Abstract][Full Text] [Related]
8. Mutants of Helicobacter pylori IMPDH: Kinetics and in silico Studies to Determine the Structural and Functional Role of Key Amino Acids.
Dilip H; Purushothaman G; Sharma G; Menon A; Thiruvenkatam V; Kirubakaran S
Chem Asian J; 2022 May; 17(9):e202200125. PubMed ID: 35293683
[TBL] [Abstract][Full Text] [Related]
9. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
Gollapalli DR; Macpherson IS; Liechti G; Gorla SK; Goldberg JB; Hedstrom L
Chem Biol; 2010 Oct; 17(10):1084-91. PubMed ID: 21035731
[TBL] [Abstract][Full Text] [Related]
11. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight indole fragments as IMPDH inhibitors.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2535-8. PubMed ID: 16483769
[TBL] [Abstract][Full Text] [Related]
14. Potential of fumarate reductase as a novel therapeutic target in Helicobacter pylori infection.
Ge Z
Expert Opin Ther Targets; 2002 Apr; 6(2):135-46. PubMed ID: 12223076
[TBL] [Abstract][Full Text] [Related]
15. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
17. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
Cuny GD; Suebsuwong C; Ray SS
Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
[TBL] [Abstract][Full Text] [Related]
18. Acid-base catalysis in the chemical mechanism of inosine monophosphate dehydrogenase.
Markham GD; Bock CL; Schalk-Hihi C
Biochemistry; 1999 Apr; 38(14):4433-40. PubMed ID: 10194364
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of Helicobacter pylori methionine aminopeptidase by azaindole hydroxamic acid derivatives: Design, synthesis, in vitro biochemical and structural studies.
Bala S; Yellamanda KV; Kadari A; Ravinuthala VSU; Kattula B; Singh OV; Gundla R; Addlagatta A
Bioorg Chem; 2021 Oct; 115():105185. PubMed ID: 34329997
[TBL] [Abstract][Full Text] [Related]
20. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
